Waldron Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Waldron Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$237K	Buy	+1,506	New	+$238K	0.01%	315
2024 Q4	–	Sell	-550	Closed	-$54.3K	–	497
2024 Q3	$54.3K	Buy	+550	New	+$54K	﹤0.01%	437
2022 Q2	–	Sell	-5,096	Closed	-$458K	–	409
2022 Q1	$458K	Buy	+5,096	New	+$471K	0.02%	262

Other funds holding XBI

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

Employees Retirement System of Texas Austin, Texas $12.2B AUM 27.55% 1-Year Est. Return

Investure LLC Charlottesville, Virginia $1.83B AUM 14.32% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Waldron Private Wealth's XBI Position: Q3 2026 in Review

Waldron Private Wealth opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 1,506 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #315 among its holdings. This is a return to the name: Waldron Private Wealth previously reported a position in XBI as recently as Q3 2024.

Waldron Private Wealth first reported a position in XBI in Q1 2022 and has held it in 3 quarters since. The position peaked at $458K in Q1 2022. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Waldron Private Wealth held 1,506 shares of State Street SPDR S&P Biotech ETF worth $237K as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new Waldron Private Wealth position in Q3 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Waldron Private Wealth's portfolio in Q3 2026, its #315 holding.
Waldron Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 3 quarters since.
Waldron Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $458K in Q1 2022.
604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Waldron Private Wealth's 13F filing for Q3 2026, filed 2 Nov 2026.